Daiichi Sankyo Unable to Ship 2.36 million Vials of Flu Vaccine Due to Virus Contamination

Daiichi Sankyo announced on September 22 that its egg culture-based seasonal influenza vaccine Kitasato Daiichi Sankyo Influenza HA Vaccine and Kitasato Daiichi Sankyo Influenza HA Vaccine Syringe did not meet the company’s quality specification test criteria and that it will...read more